期刊文献+

前列腺癌的MRI诊断:T2WI、DWI、MRS及其综合应用 被引量:41

Prostate cancer detection:comparison of T2-weighted imaging,diffusion-weighted imaging,proton magnetic resonance spectroscopy,and the combination of three techniques
下载PDF
导出
摘要 目的以病理结果为参照,探讨T2WI、DWI及MRS三种成像方法及其综合应用对前列腺癌定性诊断的价值。方法 42例患者在1.5T磁共振仪上采用体部矩阵线圈结合脊柱矩阵线圈行T2WI、DWI及3DCSI1H-MRS扫描,所有病例均经直肠穿刺活检证实。按照前列腺6分区法将所得图像数据分区评估测量,采用5分制针对各分区评分,并与病理结果对照。对三种扫描方法各自所得数据以及三种方法综合评分分别做ROC曲线分析比较,计算各组方法诊断的敏感性、特异性及准确性等。结果 42例病例中15例经穿刺证实为前列腺癌,27例为前列腺良性病变。252个分区均得到病理证实,其中201个为良性,51个为恶性。各组诊断方法的敏感性、特异性及ROC曲线下面积(Az)如下:T2WI:88.2%、67.2%和0.848±0.030,最佳诊断界值为3;DWI:82.4%、81.6%和0.860±0.033,最佳诊断界值为4;MRS:84.3%、98.0%和0.961±0.016,最佳诊断界值为5;三者综合:96.1%、96.5%和0.978±0.009,最佳诊断界值为4。结论 T2WI、DWI及MRS三种方法均可以独立有效诊断前列腺癌。三种成像方法结合诊断前列腺癌的准确性显著高于三种成像技术独立诊断,其诊断结果与病理分析一致性较好。在三种成像技术中,MRS的诊断价值较高。 Objective:To evaluate T2-weighted imaging (T2WI),diffusion-weighted imaging (DWI),MR spectroscopy (MRS),and the combination of the three MR techniques in the diagnosis of prostate cancer,as correlation with histopathologic fi ndings.Materials and Methods:MR imaging,including T2WI,DWI,and MRS,was performed at 1.5 T MR scanner with a body coil combined with a spine coil in 42 cases.Diagnosis was confi rmed by histopathology through systematic transrectal prostate biopsy.All cases were evaluated by T2WI,DWI,MRS,and then by the three methods combined.The statistical indicators and the receiver operating characteristic (ROC) curve analysis of each method were compared to histopathological fi ndings obtained by transrectal prostate biopsy.Results:Fifteen of 42 cases were confi rmed to be cancerous,and 27 of 42 cases were noncancerous.All the 252 sextants were confirmed by biopsies,including 201 benign sextants and 51 malignant sextants.The sensitivity and the specificity for the detection of prostate cancer were 88.2% and 67.2% for T2WI,as the cutoff was 3;82.4% and 81.6% for DWI,as the cutoff was 4;84.3% and 98.0% for MRS,as the cutoff was 5;and 96.1% and 96.5% for the combined T2WI+DWI+MRS,as the cutoff was 4.In the ROC analysis,the correlative areas under the ROC curves (Az) were 0.848±0.030,0.860±0.033,and 0.961±0.016 for T2WI,DWI,and MRS,respectively,and 0.978±0.009 for the combination of T2WI+DWI+MRS.Conclusion:Prostate cancer can be diagnosed effectively by T2WI,DWI and MRS separately.The diagnostic accuracy of prostate cancer is increased through a combination of the three techniques.Moreover,MRS demonstrated higher accuracy comparing with T2WI or DWI.
出处 《磁共振成像》 CAS 2010年第4期257-263,共7页 Chinese Journal of Magnetic Resonance Imaging
关键词 前列腺癌 T2加权成像 扩散加权成像 磁共振波谱学 Prostate neoplasms T2-weighted imaging Diffusion-weighted imaging Magnetic resonance spectroscopy
  • 相关文献

参考文献1

二级参考文献8

  • 1[1]Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR imaging of the in situ human prostate with high (0.24-0.7 cm3) spatial resolution[J]. Radiology, 1996, 198(3): 795-805.
  • 2[2]Cornud F, Flam T, Chauveinc, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results[J]. Radiology, 2002, 224(1): 203-210.
  • 3[5]Bartolozzi C, Crocetti L, Menchi I, et al. Endorectal magnetic resonance imaging in local staging of prostate carcinoma[J]. Abdom Imaging, 2001, 26(2): 111-122.
  • 4[6]Lowry M, Liney GP, Turnbull LW, et al. Quantification of citrate concentration in the prostate by proton magnetic spectroscopy: zonal and age-related differences[J]. Magn Reson Med, 1996, 36(3): 252-358.
  • 5[7]Kurhanewicz J, Swanson MG, Wood PJ, et al. Magnetic resonance imaging and spectroscopic imaging: improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials[J]. Urology, 2001, 57(suppl 4A): 124-128.
  • 6[8]Hahn P, Smith ICP, Leboldus L, et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra[J]. Cancer Research, 1997, 57(6): 3398-3401.
  • 7[9]Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings[J]. Radiology, 1989, 172(1): 131-137.
  • 8[10]Muramoto S, Uematsu H, Kimura H, et al. Differential of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging[J]. Euro J Radio, 2002, 44(1): 52-58.

共引文献96

同被引文献360

引证文献41

二级引证文献357

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部